Radiotherapy Industry Overview 2025: Growth Projections and Market Trends

Global Radiotherapy Market

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Radiotherapy Market Size During 2025–2029?

The radiotherapy market size has seen substantial growth recently. It is forecast to expand from $7.38 billion in 2024 to $7.89 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.0%. This past growth can be ascribed to a worldwide increase in cancer cases, a rising demand for non-invasive cancer therapies, improvements in healthcare infrastructure, greater acceptance of personalized medicine, and an expanding number of patients in need of cancer treatment.

The radiotherapy market is projected for substantial expansion in the coming years, reaching $10.27 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.8%. This anticipated growth during the forecast period is driven by factors such as enhanced investment in cutting-edge healthcare technologies, a heightened emphasis on minimally invasive treatment alternatives, growing demand for home-based healthcare provisions, a stronger focus on quality assurance protocols, and expanding global health programs aimed at cancer care. Key developments expected throughout the forecast horizon involve progress in image-guided radiotherapy, breakthroughs in particle therapy, the emergence of new brachytherapy methods, improvements in CyberKnife technology, and the incorporation of artificial intelligence into treatment planning.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21267&type=smp

What Are The Top Growth Drivers Impacting The Radiotherapy Market Outlook?

The radiotherapy market is anticipated to expand due to the rising incidence of cancer. Cancer is characterized by the uncontrolled proliferation of anomalous cells, which can infiltrate and disseminate throughout the body, originating in different tissues and organs, and manifesting in diverse forms and indications. This growing prevalence of cancer stems from several factors, including an aging demographic, shifts in lifestyle like unhealthy eating and inactivity, significant tobacco and alcohol consumption, environmental contaminants, and improved diagnostic methods that detect more cases. Radiotherapy serves a vital function in treating cancer by precisely targeting and eliminating malignant cells, thereby shrinking tumors and enhancing patient prognosis. An example highlighting this trend is a report from August 2024 by Macmillan Cancer Support, a UK-based charity aiding cancer patients, which stated that in 2024, over 3 million individuals in the UK are living with cancer, with projections indicating this number will rise to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Consequently, the expanding occurrence of cancer is a key driver for the growth of the radiotherapy market.

How Is The Radiotherapy Market Segmented?

The radiotherapymarket covered in this report is segmented –

1) By Therapy Type: External Beam Radiation Therapy; Internal Beam Radiation Therapy; Systemic Radiation Therapy

2) By Application: Prostate Cancer; Breast Cancer; Lung Cancer; Head And Neck Cancer; Colorectal Cancer; Gynecological Cancer; Cervical Cancer; Penile Cancer; Other Applications

3) By End-User: Hospitals And Diagnostic Laboratories; Cancer Treatment And Research Centers; Academic Research Organizations; Ambulatory Surgery Centers; Other End-Users

Subsegments:

1) By External Beam Radiation Therapy: Intensity-Modulated Radiation Therapy (IMRT); Stereotactic Body Radiation Therapy (SBRT); 3D Conformal Radiation Therapy (3D-CRT); Proton Beam Therapy; Image-Guided Radiation Therapy (IGRT); Volumetric Modulated Arc Therapy (VMAT)

2) By Internal Beam Radiation Therapy: Brachytherapy (High-Dose Rate); Brachytherapy (Low-Dose Rate); Intraoperative Radiation Therapy (IORT); Permanent Seed Implants

3) By Systemic Radiation Therapy: Radioisotope Therapy; Targeted Radionuclide Therapy; Radioimmunotherapy; Peptide Receptor Radionuclide Therapy (PRRT)

What Key Innovation Trends Are Fueling Advancements In The Radiotherapy Market?

Leading companies within the radiotherapy market are concentrating on developing innovative technologies, such as image-guided radiotherapy (IGRT), with the goal of enhancing treatment precision and effectiveness, improving patient outcomes, and minimizing harm to surrounding healthy tissues. Image-guided radiotherapy (IGRT) employs advanced imaging tools to ensure accurate tumor targeting during radiation treatments, boosting accuracy by tracking and adjusting the tumor’s position in real-time. For instance, in May 2022, Elekta AB, a medical technology company based in Sweden, launched the Elekta Esprit, a next-generation radiosurgery system designed to significantly enhance the capabilities of stereotactic radiosurgery. The Elekta Esprit integrates a variety of innovations within a single platform, offering superior visualization and remote accessibility for treatment teams. It supports flexible workflow options, accommodating single session, fractionated, adaptive, or staged protocols, all engineered to ensure ease of use and efficiency in clinical environments. With an accuracy of less than 0.3 mm, the system is capable of treating even the most challenging targets while minimizing damage to surrounding healthy tissues.

Which Major Industry Participants Are Leading The Radiotherapy Market Growth?

Major companies operating in the radiotherapy market are Hitachi Ltd., Koninklijke Philips N.V., GE Healthcare Technologies Inc., Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., Elekta AB, Accuray Incorporated, Ion Beam Applications S.A, Canon Medical Systems Corporation, RefleXion Medical Inc., Mevion Medical Systems Inc., Nordion Inc., Theragenics Corporation, RaySearch Laboratories AB, MIM Software Inc., Vision RT Ltd., Sun Nuclear Corporation, Provision Healthcare LLC, Panacea Medical Technologies Pvt. Ltd., Optivus Proton Therapy Inc., Perspective Therapeutics Inc., GT Medical Technologies Inc., ProTom International Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/radiotherapy-global-market-report

Which Region Is Projected To Lead The Radiotherapy Market During The Forecast Period?

North America was the largest region in the radiotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radiotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Radiotherapy Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21267&type=smp

Browse Through More Reports Similar to the Global Radiotherapy Market 2025, By The Business Research Company

Radiotherapy Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/radiotherapy-devices-global-market-report

Radiosurgery And Radiotherapy Robotics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/radiosurgery-and-radiotherapy-robotics-global-market-report

Cells Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model